Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
2023-05-10 08:44:59 ET Summary Bausch Health has been through rough times, leading to skepticism among investors. Its investment potential, however, has been on the upswing since 2016, when Joseph Papa took over as CEO. With Thomas Appio taking over and picking from where Papa...
LAVAL, QC / ACCESSWIRE / May 10, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is proud to recognize May as Mental Health Awareness Month by continuing efforts that highlight the importance of educating and supporting those with mental health care needs. With more people finding value...
2023-05-09 19:15:00 ET The S&P/TSX Composite Index was down 50 points in early afternoon trading on Tuesday, May 9. Some of the top-performing sectors included battery metals, telecom, and information technology. Today, I want to scour the TSX for some hidden gems that investors may...
2023-05-09 05:24:52 ET Summary Bausch Health has been struggling for years now following the Valeant implosion. The business has been hurt by a huge debt load and associated interest expenses. The spin-off of Bausch + Lomb has not changed the outcome either, as the business se...
Five XIFAXAN® (rifaximin) and TRULANCE® (plecanatide) Research Posters Also to Be Presented LAVAL, QC / ACCESSWIRE / May 8, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), the gastroenterology (GI) busines...
2023-05-04 12:52:48 ET Bausch Health Companies ( NYSE: BHC ) stock fell ~17% on Thursday after Q1 results missed estimates. Adjusted net income attributable to BHC declined -27.3% Y/Y to $191M. Net loss attributable BHC widened to -$201M, compared to -$69M in Q1 2022, ma...
2023-05-04 12:24:09 ET Bausch Health Companies Inc. (BHC) Q1 2023 Earnings Conference Call May 4, 2023 8:00 AM ET Company Participants Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Mark Maico - Investor Relations Conference C...
2023-05-04 07:55:52 ET Bausch Health Companies press release ( NYSE: BHC ): Q1 GAAP EPS of $0.55 beats by $0.68 . Adjusted net income attributable to Bausch Health (non-GAAP) for the first quarter of 2023 was $191 million Revenue of $1.94B (+1.0% Y/Y) misses...
First-Quarter revenues of $1.94 billion, up 1% reported and 4% organic 1 Solid revenue growth across core products, led by Xifaxan with 7% reported growth Mid- and late-stage product pipeline advancing Bausch Health provides consolidated full-year guidance, and Bausch Health (excl. B+L)...
2023-05-03 13:51:49 ET Bausch Health Companies ( NYSE: BHC ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open. The consensus EPS Estimate is $0.68 (+457.9% Y/Y) and the consensus Revenue Estimate is $1.95B (+1.6% Y/Y). Over the last...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two new members to its Executive Leadership Team (ELT). Jean-Jacques Charhon ("JJ") will join the Company as Chief Financial Officer on August 19, 2024. JJ has over 25 ...
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...
The S&P 500 rose to a new high on Friday, putting the broad-market index on track for yet another weekly gain during the holiday-shortened trading week. The tech-heavy NASDAQ Composite also hit a new high. The Dow Jones Industrials climbed 67.87 points to end Friday at 39,375.87. The ...